Acton, MA, United States of America

Qing Liu

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 12.7

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2013-2025

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: The Innovations of Qing Liu

Introduction

Qing Liu is a prominent inventor based in Acton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 7 patents to his name, Liu's work has the potential to impact various medical treatments.

Latest Patents

One of Liu's latest patents involves Anti-GDF-15 antibodies. These monoclonal antibodies are designed to bind and inhibit the activity of human GDF15. The implications of this invention are substantial, as these antibodies can be utilized to treat body weight loss, including cachexia, which is associated with the over-expression of human GDF15. This innovative approach could provide new avenues for treating patients suffering from weight loss due to various medical conditions.

Career Highlights

Qing Liu is currently associated with Aveo Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Aveo Pharmaceuticals has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of Liu's notable coworkers include Lorena Lerner and Ting Chen. Their collaborative efforts contribute to the innovative environment at Aveo Pharmaceuticals, fostering advancements in biotechnology.

Conclusion

Qing Liu's contributions to the field of biotechnology, particularly through his patents on Anti-GDF-15 antibodies, highlight his role as a leading inventor. His work not only showcases his innovative spirit but also holds promise for improving medical treatments for patients facing significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…